China pharma company expects covid vaccine to be ready for mass use by year end1 min read 18 Aug 2020, 02:11 PM IST
Sinopharm has said its experimental vaccine could be ready for public use by the end of this year
Moderna Inc said earlier this month that smaller volumes of its experimental vaccine have been priced at $32-$37 per dose
BEIJING : A potential coronavirus vaccine being developed by a unit of China National Pharmaceutical Group (Sinopharm) could cost no more than 1,000 yuan ($144.27) for two shots, state media on Tuesday quoted chairman Liu Jingzhen as saying.
Select your Category